Profiel
Christina Trojel-Hansen is the founder of Oscine Corp.
She previously worked as a Senior Associate at Novo Seeds from 2016 to 2018.
Eerdere bekende functies van Christina Trojel-Hansen
| Bedrijven | Functie | Einde |
|---|---|---|
Oscine Corp.
 Oscine Corp. BiotechnologyHealth Technology Oscine Corp. engages in the development of cell therapies for diseases of the brain and central nervous system (CNS). It offers cell platform that generates bi-potential astrocyte-oligodendrocyte glial progenitor cells. The company was founded by Steven Alan Goldman and Christina Trojel-Hansen and is headquartered in Rochester, NY. | Algemeen Directeur | 01-09-2020 |
Novo Seeds
 Novo Seeds Investment ManagersFinance Novo Seeds (Novo Seeds) is a venture capital operating division of Novo Nordisk Fonden. The firm was established in 2007, and is headquartered in Hellerup, Denmark. | Private Equity Analist | 01-04-2018 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Novo Seeds
Novo Seeds Investment ManagersFinance Novo Seeds (Novo Seeds) is a venture capital operating division of Novo Nordisk Fonden. The firm was established in 2007, and is headquartered in Hellerup, Denmark. | Finance |
Oscine Corp.
Oscine Corp. BiotechnologyHealth Technology Oscine Corp. engages in the development of cell therapies for diseases of the brain and central nervous system (CNS). It offers cell platform that generates bi-potential astrocyte-oligodendrocyte glial progenitor cells. The company was founded by Steven Alan Goldman and Christina Trojel-Hansen and is headquartered in Rochester, NY. | Health Technology |
